No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use
-
Arthroscopy / adverse effects
-
Blood Loss, Surgical / prevention & control*
-
Dabigatran / administration & dosage
-
Dabigatran / therapeutic use
-
Factor VIII / therapeutic use
-
Hemophilia A / drug therapy*
-
Humans
-
Randomized Controlled Trials as Topic
-
Rivaroxaban / therapeutic use
-
Single-Domain Antibodies / therapeutic use
-
Venous Thromboembolism / prevention & control*
Substances
-
Antibodies, Monoclonal, Humanized
-
Anticoagulants
-
Single-Domain Antibodies
-
recombinant factor VIII N8
-
caplacizumab
-
F8 protein, human
-
Factor VIII
-
idarucizumab
-
Rivaroxaban
-
Dabigatran